Clinical Trials Logo

Clinical Trial Summary

The investigators want to prove that people WITHOUT advanced cancer who are taking opioid medications (for problems like back pain) can receive methylnaltrexone (MNTX) safely. Since the FDA has only approved MNTX for advanced cancer patients, the investigators' research is investigating how MNTX can work for NON-cancer patients. This research is being conducted to prove that MNTX can work for non-cancer patients with opioid related constipation.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00949377
Study type Interventional
Source Beth Israel Medical Center
Contact
Status Withdrawn
Phase Phase 4
Start date September 2009
Completion date December 2011

See also
  Status Clinical Trial Phase
Completed NCT01230840 - Effect of Wheat Dextrin on Calcium and Magnesium Absorption Phase 4